Efficacy of Olmesartan on Cerebral Glucose Metabolism Vascular Inflammation and Adipose Tissue

  • STATUS
    Not Recruiting
  • participants needed
    100
  • sponsor
    Kurume University
Updated on 21 January 2021
Investigator
Nobuhiro Tahara, MD, PhD
Primary Contact
Kurume University Hospital (0.6 mi away) Contact

Summary

Hypertension is a leading risk factor for morbidity and mortality worldwide. The brain is a major target of the damaging effects of hypertension. Hypertension has been recognized as the leading cause of dementia as well as the most important risk factor for stroke and vascular cognitive impairment. Although glucose is the principal cerebral energy source, impact of hypertensive treatment on cerebral glucose metabolism is poorly understood.

Details
Treatment Amlodipine, Olmesartan
Clinical Study IdentifierNCT02996916
SponsorKurume University
Last Modified on21 January 2021

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet